Craft

Caris Life Sciences

Revenue

$812 M

FY, 2025

Caris Life Sciences Summary

Company Summary

Overview
Caris Life Sciences is a molecular science company that provides cancer care services. It offers blood and tissue profiling, clinical discovery, trials, research and development, commercialization, precision oncology, and other solutions.
Type
Public
Status
Active
Founded
2008
HQ
Irving, TX, US | view all locations
Website
https://www.carislifesciences.com
Cybersecurity rating
Sectors

Key People

  • David Dean Halbert

    David Dean Halbert, Chairman, Founder and CEO

    • Chadi Nabhan

      Chadi Nabhan, Chairman, Precision Oncology Alliance

      • David Spetzler

        David Spetzler, President, Chief Scientific Officer

      • Stephanie Thomas

        Stephanie Thomas, Executive Vice President, Chief of Staff, Office of the CEO

        Operating MetricsView all

        Products and Services

        4

        Feb, 2023

        Locations

        6

        Feb, 2023

        Expertise Areas

        8

        Feb, 2023

        LocationsView all

        10 locations detected

        • Irving, TX HQ

          United States

          750 West John Carpenter Freeway Suite 800

        • Cambridge, MA

          United States

          245 Main Street

        • Irving, TX

          United States

          3600 W Royal Lane

        • New York, NY

          United States

          510 Madison Ave, 10th Floor

        • Phoenix, AZ

          United States

          4415 E. Cotton Center Blvd., Suite 100

        • Phoenix, AZ

          United States

          4550 S. 44th Place

        and 4 others

        Caris Life Sciences Financials

        Summary Financials

        Revenue (Q1, 2026)
        $216.2M
        Net income (Q1, 2026)
        ($510.0K)
        Cash (Q1, 2026)
        $819.9M
        EBIT (Q1, 2026)
        $5.3M

        Footer menu